Free Trial

NEXGEL (NXGLW) Competitors

NEXGEL logo
$0.05 0.00 (-1.80%)
As of 05/14/2026 03:30 PM Eastern

NXGLW vs. DRTSW, ANZUW, HSCSW, BEATW, and LUCYW

Should you buy NEXGEL stock or one of its competitors? MarketBeat compares NEXGEL with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NEXGEL include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), and Innovative Eyewear (LUCYW). These companies are all part of the "medical equipment" industry.

How does NEXGEL compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and NEXGEL (NASDAQ:NXGLW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
NEXGEL$11.42MN/AN/AN/AN/A

In the previous week, Alpha Tau Medical and Alpha Tau Medical both had 4 articles in the media. NEXGEL's average media sentiment score of 0.47 beat Alpha Tau Medical's score of 0.19 indicating that NEXGEL is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
NEXGEL
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
NEXGEL N/A N/A N/A

Summary

NEXGEL beats Alpha Tau Medical on 2 of the 2 factors compared between the two stocks.

How does NEXGEL compare to Anzu Special Acquisition Corp I?

NEXGEL (NASDAQ:NXGLW) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

In the previous week, NEXGEL had 4 more articles in the media than Anzu Special Acquisition Corp I. MarketBeat recorded 4 mentions for NEXGEL and 0 mentions for Anzu Special Acquisition Corp I. NEXGEL's average media sentiment score of 0.47 beat Anzu Special Acquisition Corp I's score of 0.00 indicating that NEXGEL is being referred to more favorably in the media.

Company Overall Sentiment
NEXGEL Neutral
Anzu Special Acquisition Corp I Neutral

Company Net Margins Return on Equity Return on Assets
NEXGELN/A N/A N/A
Anzu Special Acquisition Corp I N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NEXGEL$11.42MN/AN/AN/AN/A
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A

Summary

NEXGEL beats Anzu Special Acquisition Corp I on 3 of the 3 factors compared between the two stocks.

How does NEXGEL compare to Heart Test Laboratories?

NEXGEL (NASDAQ:NXGLW) and Heart Test Laboratories (NASDAQ:HSCSW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

In the previous week, NEXGEL had 3 more articles in the media than Heart Test Laboratories. MarketBeat recorded 4 mentions for NEXGEL and 1 mentions for Heart Test Laboratories. Heart Test Laboratories' average media sentiment score of 1.87 beat NEXGEL's score of 0.47 indicating that Heart Test Laboratories is being referred to more favorably in the news media.

Company Overall Sentiment
NEXGEL Neutral
Heart Test Laboratories Very Positive

Company Net Margins Return on Equity Return on Assets
NEXGELN/A N/A N/A
Heart Test Laboratories N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NEXGEL$11.42MN/AN/AN/AN/A
Heart Test Laboratories$8.67KN/AN/AN/AN/A

Summary

NEXGEL beats Heart Test Laboratories on 2 of the 3 factors compared between the two stocks.

How does NEXGEL compare to HeartBeam?

NEXGEL (NASDAQ:NXGLW) and HeartBeam (NASDAQ:BEATW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

In the previous week, NEXGEL had 2 more articles in the media than HeartBeam. MarketBeat recorded 4 mentions for NEXGEL and 2 mentions for HeartBeam. HeartBeam's average media sentiment score of 1.44 beat NEXGEL's score of 0.47 indicating that HeartBeam is being referred to more favorably in the news media.

Company Overall Sentiment
NEXGEL Neutral
HeartBeam Positive

Company Net Margins Return on Equity Return on Assets
NEXGELN/A N/A N/A
HeartBeam N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NEXGEL$11.42MN/AN/AN/AN/A
HeartBeamN/AN/AN/AN/AN/A

Summary

NEXGEL beats HeartBeam on 2 of the 3 factors compared between the two stocks.

How does NEXGEL compare to Innovative Eyewear?

NEXGEL (NASDAQ:NXGLW) and Innovative Eyewear (NASDAQ:LUCYW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation and profitability.

In the previous week, NEXGEL had 3 more articles in the media than Innovative Eyewear. MarketBeat recorded 4 mentions for NEXGEL and 1 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 1.92 beat NEXGEL's score of 0.47 indicating that Innovative Eyewear is being referred to more favorably in the news media.

Company Overall Sentiment
NEXGEL Neutral
Innovative Eyewear Very Positive

Company Net Margins Return on Equity Return on Assets
NEXGELN/A N/A N/A
Innovative Eyewear N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NEXGEL$11.42MN/AN/AN/AN/A
Innovative Eyewear$2.66MN/AN/AN/AN/A

Summary

NEXGEL beats Innovative Eyewear on 2 of the 3 factors compared between the two stocks.

Get NEXGEL News Delivered to You Automatically

Sign up to receive the latest news and ratings for NXGLW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NXGLW vs. The Competition

MetricNEXGELMedical Instruments & Supplies IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.74B$6.34B$12.37B
Dividend YieldN/A2.01%2.80%5.35%
P/E RatioN/A16.0920.6625.63
Price / SalesN/A88.19547.7676.59
Price / CashN/A146.5443.2656.33
Price / BookN/A2.849.886.97
Net IncomeN/A$99.80M$3.55B$333.62M
7 Day PerformanceN/A-0.78%1.69%1.09%
1 Month PerformanceN/A1.52%0.48%3.08%
1 Year PerformanceN/A-10.33%39.39%35.68%

NEXGEL Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NXGLW
NEXGEL
N/A$0.05
-1.8%
N/A-88.9%$0.00$11.42MN/A10
DRTSW
Alpha Tau Medical
N/A$1.80
+2.3%
N/A+778.9%$0.00N/AN/A80
ANZUW
Anzu Special Acquisition Corp I
N/A$0.07
flat
N/AN/A$0.00N/AN/A2
HSCSW
Heart Test Laboratories
N/A$0.06
+0.3%
N/A+74.5%$0.00$8.67KN/A10
BEATW
HeartBeam
N/A$0.08
-10.1%
N/A-83.2%$0.00N/AN/A5

Related Companies and Tools


This page (NASDAQ:NXGLW) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners